Studying the pathology and learning to treat Alzheimer's disease - from model to drug target

The team Molecular Psychiatry focusses on thebasis of Alzheimer’s disease, its etiology, identification of influencing factors and the development of novel drug targets. We are studying the molecular triggers causing neuron loss and the consequences of the cellular loss on learning and memory deficits in the animal model. Furthermore, which molecular processes are involved. One major focus is the development of therapeutic antibodies and their validation as potential drugs to fight Alzheimer’s disease.